Healthcare provider profile · identity verified

Kenneth Wells, M.D.

Family Practice · JAMESTOWN, RI · NPI 1629097506

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	567	165
Losartan Potassium	Losartan Potassium	338	110
Lisinopril	Lisinopril	328	104
Amlodipine Besylate	Amlodipine Besylate	321	83
Levothyroxine Sodium	Levothyroxine Sodium	275	72
Hydrochlorothiazide	Hydrochlorothiazide	269	85
Omeprazole	Omeprazole	255	69
Gabapentin	Gabapentin	244	65
Trazodone Hcl	Trazodone Hcl	243	71
Metoprolol Succinate	Metoprolol Succinate	230	59
Rosuvastatin Calcium	Rosuvastatin Calcium	175	53
Metformin Hcl	Metformin Hcl	160	49
Fluticasone Propionate	Fluticasone Propionate	139	68
Simvastatin	Simvastatin	127	38
Albuterol Sulfate Hfa	Albuterol Sulfate	124	37
Tamsulosin Hcl	Tamsulosin Hcl	120	44
Duloxetine Hcl	Duloxetine Hcl	118	30
Pravastatin Sodium	Pravastatin Sodium	114	34
Oxycodone Hcl	Oxycodone Hcl	102	14
Allopurinol	Allopurinol	101	32
Eliquis	Apixaban	91	25
Sertraline Hcl	Sertraline Hcl	90	29
Meloxicam	Meloxicam	89	22
Famotidine	Famotidine	87	22
Escitalopram Oxalate	Escitalopram Oxalate	81	18
Pantoprazole Sodium	Pantoprazole Sodium	74	24
Metoprolol Tartrate	Metoprolol Tartrate	72	23
Citalopram Hbr	Citalopram Hydrobromide	69	16
Doxycycline Monohydrate	Doxycycline Monohydrate	68	57
Furosemide	Furosemide	63	22
Jardiance	Empagliflozin	63	14
Lorazepam	Lorazepam	60	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	14
Alprazolam	Alprazolam	55	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	53	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	13
Metformin Hcl Er	Metformin Hcl	53	17
Mirtazapine	Mirtazapine	53	15
Alendronate Sodium	Alendronate Sodium	46	15
Valacyclovir	Valacyclovir Hcl	40	19
Potassium Chloride	Potassium Chloride	39	suppressed
Propranolol Hcl	Propranolol Hcl	39	suppressed
Montelukast Sodium	Montelukast Sodium	38	13
Atenolol	Atenolol	37	13
Prednisone	Prednisone	37	23
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	30
Venlafaxine Hcl Er	Venlafaxine Hcl	36	12
Bupropion Xl	Bupropion Hcl	34	12
Ibuprofen	Ibuprofen	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	11
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Tramadol Hcl	Tramadol Hcl	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	32	suppressed
Ozempic	Semaglutide	32	11
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Xarelto	Rivaroxaban	30	suppressed
Amoxicillin	Amoxicillin	28	25
Clopidogrel	Clopidogrel Bisulfate	28	11
Ketoconazole	Ketoconazole	28	15
Buspirone Hcl	Buspirone Hcl	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	13
Ezetimibe	Ezetimibe	27	12
Paxlovid	Nirmatrelvir/Ritonavir	27	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	12
Methocarbamol	Methocarbamol	26	12
Methadone Hcl	Methadone Hcl	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Nystatin	Nystatin	24	13
Xtampza Er	Oxycodone Myristate	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Linzess	Linaclotide	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	22	suppressed
Finasteride	Finasteride	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Glipizide	Glipizide	21	suppressed
Naproxen	Naproxen	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	11
Pregabalin	Pregabalin	21	suppressed
Ramelteon	Ramelteon	21	suppressed
Colchicine	Colchicine	20	11
Lactulose	Lactulose	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Rizatriptan	Rizatriptan Benzoate	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	15	suppressed
Carvedilol	Carvedilol	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Premarin	Estrogens, Conjugated	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Estradiol	Estradiol	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Prasugrel Hcl	Prasugrel Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error